Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, octubre 23
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Bausch Health Companies Inc
BHC
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$6.49
N/A
Últ. Act.: Oct 22, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 5 días de ahora en mié oct 28th, después del cierre del mercado
Conferencia telefónica:
Conferencia telefónica programada para dentro de 5 días a las 5:00 p. m.
Haz clic para ver el webcast
Bausch Health Companies Financials
Bausch Health Companies (BHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Why Is Bausch + Lomb Stock Falling Monday?
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
Neeraj Jain
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share
Benzinga Newsdesk
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs $10.595B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion to $10.670 billion-$10.920 billion vs $10.595 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.69 by 13.04 percent. This is a 27.87 percent increase over earnings of $0.61 per share
Benzinga Newsdesk
